CDMO Sterling Pharma Solutions has announced what it called the next phase of a multi-year investment strategy at its site in Dudley, UK. It will spend £10 million by mid-2022 on new process development laboratories and commercial-scale manufacturing equipment to meet growth in demand for small molecule API manufacturing.
Indorama Ventures (IVL) has become the first company in Thailand to publish a report lined to the UN’s Sustainable Development Goals (SDGs). This came shortly after the firm launched a THB 10 billion (€260 million) sustainability-linked bond (SLB).
Packaging giant Cascades has chosen Kemira as the primary chemical supplier for the Bear Island mill in Virginia, which it is converting to produce lightweight 100% recycled linerboard and medium grades. This is due to be completed by the end of 2022 and to have 465,00 tonnes/year of capacity when in full operation.
Cabot has agreed to sell its Purification Solutions business, which makes activated carbon for a wide range of applications, to private equity firm One Equity Partners. President and CEO Sean Keohane said that this “will allow us to focus resources on our core business segments and invest in areas where we see strong future growth and innovation potential for Cabot, such as battery materials”.
Advent International, one of the world’s largest private equity investors, has agreed to buy Netherlands-based distributor Caldic from Goldman Sachs Asset Management in a deal that should close in 1H 2022. Terms were not disclosed.
Caldic is active in life sciences and speciality chemicals, employing around 1,200 people across 35 sites in Europe, North America and the Asia-Pacific and turning over about €1 billion in 2020. Advent intends to merge it with its existing operation Grupo Transmerquim (GTM), one of only two chemical distributors to cover the whole of Latin America.
German- and Swiss-based CABB Group is to create a new unified organisation called ‘One CABB’. As part of this the Custom Manufacturing and Acetyls business units will be combined. “Both units serve overlapping customer bases while utilising similar technologies in their production,” the firm said.
“Through the change to ‘One CABB’ we will gain speed and efficiency and thus strengthen our position as one of the premier contract development and manufacturing companies,” added CEO Valerie Diele-Braun (pictured).
Distributor IMCD has agreed to acquire Megasetia Agung Kimia, which it said “provides a significant platform for further growth in the life science segments in Indonesia”. This will take place in two tranches, with 70% being bought now and the rest in 2025. Closing is expected in December.
